Brompheniramine/dextromethorphan/phenylephrine FDA Alerts
The FDA Alerts below may be specifically about brompheniramine/dextromethorphan/phenylephrine or relate to a group or class of drugs which include brompheniramine/dextromethorphan/phenylephrine.
MedWatch Safety Alerts are distributed by the FDA and published by Drugs.com. Following is a list of possible medication recalls, market withdrawals, alerts and warnings.
Recent FDA Alerts for brompheniramine/dextromethorphan/phenylephrine
Dextromethorphan
FDA issued a Talk Paper to notify the public about the abuse of dextromethorphan (DXM), an ingredient found in many over-the-counter (OTC) cough and cold remedies. The agency is working with other health and law enforcement authorities to address this serious issue and warn the public of potential harm, after five recently reported deaths of teenagers that may be associated with the consumption of powdered DXM sold in capsules.[May 20, 2005 - Talk Paper - FDA]
More brompheniramine/dextromethorphan/phenylephrine resources
- Brotapp PE-DM Cough And Cold Consumer Information
- Children's Cold and Cough DM Consumer Information
- Cold and Cough Childrens Consumer Information
- Dimaphen DM Childrens Consumer Information
- Dimetapp Cold and Cough Childrens Consumer Information
- Brompheniramine, dextromethorphan, and phenylephrine Consumer Information
- Alahist DM (Brompheniramine, Dextromethorphan, and Phenylephrine) Consumer Information
- Dimetapp Cold Relief Childrens Consumer Information
- Dimetapp DM Cold/Cough Consumer Information
- Phenylephrine Complex Prescribing Information